Abciximab combined with angioplasty in a patient with renal artery stent subacute thrombosis.
Following renal artery angioplasty and stenting, a female hypertensive patient suffered left renal artery stent subacute thrombosis. A second successful angioplasty was performed using 5000 U heparin i.v. and 0.25-mg/kg bolus followed by a 12-hr 10-microg/min infusion of abciximab. Normal renal flow was re-established and remained normal at 1-year follow-up.
Berkompas
D C
DC
Thoracic and Cardiovascular Institute, Lansing, Michigan 48910, USA.
D000077284:Abciximab; D017130:Angioplasty / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D001783:Blood Flow Velocity; D005260:Female; D005500:Follow-Up Studies; D006083:Graft Occlusion, Vascular / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D011475:Prosthesis Failure; D011859:Radiography; D012077:Renal Artery / Q000000981:diagnostic imaging; D012078:Renal Artery Obstruction / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D012086:Reoperation; D015607:Stents; D014463:Ultrasonography
D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D006493:Heparin; D000077284:Abciximab